A 22-year-old woman attends the STI clinic with a 3-day history of dysuria, urinary frequency, and mucopurulent urethral discharge. On examination, she is afebrile with no systemic signs. Gram stain of urethral smear shows gram-negative intracellular diplococci within neutrophils. She reports unprotected sexual contact 5 days ago. What is the most appropriate immediate next step in management?

Explanation

## Clinical Diagnosis: Acute Gonococcal Urethritis This is a straightforward case of **Neisseria gonorrhoeae** infection: - Classic presentation: dysuria, urinary frequency, mucopurulent discharge - Gram stain finding: gram-negative intracellular diplococci (pathognomonic for gonorrhea in symptomatic women) - Timeline: symptoms within 5 days of exposure (typical incubation 2–5 days) - No systemic signs (uncomplicated urethritis) **High-Yield:** Gram stain is highly specific (>95%) for gonorrhea in symptomatic women when showing gram-negative intracellular diplococci. Treatment should NOT be delayed pending culture. ## Current Treatment Guidelines for Gonorrhea **Key Point:** Due to widespread resistance to fluoroquinolones and tetracyclines, **cephalosporin monotherapy is no longer recommended**. Current first-line therapy is **ceftriaxone + azithromycin** (or doxycycline if azithromycin contraindicated). | Regimen | Status | Reason | |---------|--------|--------| | Ceftriaxone 250 mg IM + azithromycin 1 g PO | **First-line** | Covers both N. gonorrhoeae and C. trachomatis; delays resistance | | Ceftriaxone 250 mg IM + doxycycline 100 mg BD × 7 days | **Alternative** | If azithromycin contraindicated | | Fluoroquinolones (ciprofloxacin, ofloxacin) | **NOT recommended** | Widespread resistance (>50% in many regions) | | Tetracyclines alone | **NOT recommended** | Resistance common; poor gonorrhea coverage | | Cephalosporin monotherapy | **NOT recommended** | Increases selection pressure for resistance | **Clinical Pearl:** The dual therapy (cephalosporin + macrolide) approach is used to: 1. Cover both N. gonorrhoeae and C. trachomatis (which coexist in 30–50% of cases) 2. Reduce emergence of cephalosporin resistance 3. Achieve high cure rates (>98%) ## Contact Tracing and Public Health **Key Point:** Gonorrhea is a notifiable disease in India. All sexual contacts within the preceding 60 days must be traced, tested, and treated to prevent reinfection and further transmission. ## Why Other Options Are Incorrect ```mermaid flowchart TD A[Gram-negative intracellular diplococci on Gram stain]:::outcome --> B{Treat immediately or defer?}:::decision B -->|Defer for culture| C[❌ Delays therapy, risks complications]:::urgent B -->|Treat immediately| D[✓ Standard of care]:::action D --> E{Which antibiotic?}:::decision E -->|Fluoroquinolone monotherapy| F[❌ Resistance >50%, poor efficacy]:::urgent E -->|Cephalosporin monotherapy| G[❌ Increases resistance, suboptimal]:::urgent E -->|Cephalosporin + macrolide| H[✓ First-line, covers gonorrhea + chlamydia]:::action H --> I[Contact tracing + counseling]:::action ``` **Mnemonic:** **"CRAM"** for gonorrhea treatment — **C**eftriaxone, **R**esistance prevention, **A**zithromycin (or doxycycline), **M**ultiple partners (contact tracing). ## Why Deferring Treatment Is Wrong 1. **Gram stain is diagnostic** — In symptomatic women, gram-negative intracellular diplococci have >95% specificity for gonorrhea. Treatment should not be delayed. 2. **Risk of complications** — Untreated gonorrhea can ascend to cause pelvic inflammatory disease (PID), tubo-ovarian abscess, and infertility. 3. **Continued transmission** — Delaying treatment prolongs infectivity and allows spread to contacts.